NIH Guide: SMALL GRANT PROGRAM FOR THE NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS

Full Text PA-95-007

SMALL GRANT PROGRAM FOR THE NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS

NIH GUIDE, Volume 23, Number 40, November 18, 1994

PA NUMBER: PA-95-007

P.T. 34

Keywords:
Communicative Disorders, Hearing
Communicative Disorders, Speech
Hearing
0775017

National Institute on Deafness and Other Communications Disorders

PURPOSE

This program announcement supersedes previous announcements of the
National Institute on Deafness and Other Communication Disorders
(NIDCD) Small Grant Program. This current Small Grant (R03) Program
provides support for pilot research that is likely to lead to a
subsequent individual research project grant (R01) or a First
Independent Research Support and Transition (FIRST) (R29) award
application. The research must be focused on areas within the
mission of the NIDCD, that is, hearing, balance/vestibular, smell,
taste, voice, speech, or language.

HEALTHY PEOPLE 2000

The Public Health Service (PHS) is committed to achieving the health
promotion and disease prevention objectives of "Healthy People 2000,"
a PHS-led national activity for setting priority areas. This program
announcement, Small Grant Program for the NIDCD, is related to the
priority area of clinical prevention services. Potential applicants
may obtain a copy of "Healthy People 2000" (Full Report: Stock No.
017-001-11474-0) or "Healthy People 2000" (Summary Report: Stock No.
017-001-11473-1) through the Superintendent of Documents, Government
Printing Office, Washington, DC 20402-9325 (telephone 202-783-3238).

ELIGIBILITY REQUIREMENTS

Applications may be submitted by domestic for-profit and non-profit
organizations, public and private, such as universities, colleges,
hospitals, laboratories, units of State and local governments, and
eligible agencies of the Federal government. Racial/ethnic minority
individuals, women, and persons with disabilities are encouraged to
apply as principal investigators. Foreign organizations and
institutions are not eligible. Current and previous recipients of
NIH research grants such as small grant (R03) research projects
grants (R01), or FIRST (R29) awards are ineligible for this small
grant program, as are Principal Investigators of research subprojects
of P01/P50/P60 grants. Individuals who have received research
support from the National Science Foundation (NSF) are considered
ineligible. Recipients of NIH Academic Research Enhancement Awards
(R15) or Clinical Investigator Development Awards (K08) are eligible
for this small grant program. Participation in the program by
investigators at minority institutions is strongly encouraged. Small
grant funds may not be used to support thesis or dissertation
research.

MECHANISM OF SUPPORT

Applicants may request up to $25,000 (direct costs) per year through
the small grant (R03) mechanism. The grant may not exceed two years
and is not renewable. Before completion of the R03, investigators
are encouraged to seek continuing support for research through a
research project grant (R01) or FIRST (R29) award.

RESEARCH OBJECTIVES

The Small Grant program is designed to support basic and clinical
scientists who are at the beginning stages of their independent
research careers.

INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN
SUBJECTS

It is the policy of the NIH that women and members of minority groups
and their subpopulations must be included in all NIH supported
biomedical and behavioral research projects involving human subjects,
unless a clear and compelling rationale and justification are
provided that inclusion is inappropriate with respect to the health
of the subjects of the purpose of the research. This new policy
results from the NIH Revitalization Act of 1993 (Section 492B of
Public Law 103-43) and supersedes and strengthens the previous
policies (Concerning the Inclusion of Women in Study Populations, and
Concerning the Inclusion of Minorities in Study Populations) which
have been in effect since 1990. The new policy contains some
provisions that are substantially different from the 1990 policies.

All investigators proposing research involving human subjects should
read the "NIH Guidelines for Inclusion of Women and Minorities as
Subjects in Clinical Research", which have been published in the
Federal Register of March 28, 1994 (FR 59 14508-14513) and reprinted
in the NIH Guide for Grants and Contracts, Volume 23, Number 11,
March 18, 1994.

Investigators also may obtain copies of the policy from the program
staff listed under INQUIRIES. Program staff may also provide
additional relevant information concerning the policy.

APPLICATION PROCEDURES

The submission, review, and award schedule for the Small Grant
Program for FY 95 (these dates likely will differ for FY 96) is:

Application Receipt Dates for FY95: 12/21/94 04/11/95 08/18/95
Institute Committee Review: Feb-Mar Jun-Jul Oct-Nov
Council Review: May Oct Jan
Earliest Funding: Jul Dec Apr

Only one Small Grant application may be submitted by a principal
investigator per receipt date. Applicants may not submit R01 or R29
applications on the same topic concurrently (to be considered at the
same National Advisory Council cycle) with the submission of a Small
Grant application.

Applications are to be submitted on the grant application form PHS
398 (rev. 9/91) and prepared according to the directions in the
application packet, with the exceptions noted below.

Application kits are available at most institutional offices of
sponsored research and may be obtained from the Office of Grants
Information, Division of Research Grants, National Institutes of
Health, Westwood Building, Room 449, Bethesda, MD 20892, telephone
301-710-0267.

On the face page of the application: Item 2a Type "Small Grant
Program NIDCD". Check the "YES" box.

Sections 1-4: Do not exceed a total of five pages for the following
sections: specific aims, background and significance, progress
report/preliminary studies, and experimental design and methods.
Tables and figures are included in the five page limitation. For
revised applications, an additional introduction not to exceed one-
half page is allowed. This introduction should respond to the
comments and concerns of the Initial Review Group delineated in the
summary statement. Applications that exceed the page limitation or
NIH requirements for type size and margins (Refer to PHS 398
application for details) will be returned to the investigator. The
five page limitation does not include Sections 5-9 (Human Subjects,
Consortia, Literature cited). Appendix materials generally are not
allowed.

Use the mailing label in the application kit to mail the original and
four copies of the application to:

Division of Research Grants
National Institutes of Health
Westwood Building, Room 240
Bethesda, MD 20892**

To ensure that the application is received in sufficient time for the
review, send one copy of the application to:

Acting Chief, Scientific Review Branch
National Institute on Deafness and Other Communication Disorders
Executive Plaza South, Room 400-C
6120 Executive Boulevard MSC 7180
Bethesda, MD 20892-7180

REVIEW CONSIDERATIONS

A review committee of the NIDCD will evaluate each Small Grant
application in accordance with the usual NIH peer review procedures
and criteria. Applications will be evaluated with respect to the
following criteria:

o Scientific, technical, or clinical significance and originality of
the proposed research.
o Appropriateness and adequacy of the experimental approach and
methodology proposed to carry out the research.
o Appropriateness of the statistical methods proposed to analyze the
results.
o Potential of the proposed studies to lead to more extensive
research.
o Qualifications and research experience of the principal
investigator.
o Availability of resources necessary for the research, including
any needed to supplement the budget.
o Appropriateness of the proposed budget and timetable in relation
to the scope of the proposed research.
o The adequacy of the proposed means for protecting against or
minimizing potential adverse effects upon humans, animals, or the
environment.
o Adequacy of adherence to guidelines for including gender and
minority representation in any study population.

Applications subsequently will be reviewed by the National Deafness
and Other Communication Disorders Advisory Council.

AWARD CRITERIA

The award of grants is contingent on the (1) receipt of applications
of high scientific merit; (2) responsiveness to this program
announcement, including the eligibility of investigators; (3)
relevance to the mission of NIDCD; and (4) the availability of
appropriated funds.

INQUIRIES

Inquiries are encouraged. The opportunity to clarify any issues or
questions from potential applicants is welcome

Direct inquiries regarding programmatic issues to:

Hearing
Dr. Kenneth Gruber
Telephone: (301) 402-3458\
Email: GruberK%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov

Balance/Vestibular
Dr. Daniel Sklare
Telephone: (301) 496-1804
Email: SklareD%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov

Smell/Taste
Dr. Jack Pearl
Telephone: (301) 402-3464
Email: PearlJ%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov

Smell/Taste
Dr. Rochelle Small
Telephone: (301) 402-3464
Email: SmallR%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov

Voice/Speech
Dr. Beth Ansel
Telephone: (301) 402-3461
Email: AnselB%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov

Language
Dr. Judith Cooper
Telephone: (301) 496-5061
Email: CooperJ%NIDCD-EPS%NIH@fedtcp.ninds.nih.gov

The address and FAX number for all the above is:
Division of Communication Sciences and Disorders
National Institute on Deafness and Other Communication Disorders
Executive Plaza South, Room 400-C
6120 Executive Boulevard MSC 7180
Bethesda, MD 20892
FAX: (301)402-6251

Direct inquiries regarding fiscal matters to:

Sharon Hunt
Grants Management Office
National Institute on Deafness and Other Communication Disorders
Executive Plaza South, Room 400-B
6120 Executive Boulevard MSC 7180
Bethesda, MD 20892-7180
Telephone: (301) 402-0909

AUTHORITY AND REGULATIONS

This program is described in the Catalog of Federal Domestic
Assistance No. 93.173. Awards are made under authorization of the
Public Health Service Act, Title IV, Part A (Public Law 78-410), as
amended by Public Law 99-158, 42 USC 241 and 285) and administered
under PHS grants policies and Federal Regulations 42 CFR 52 and 45
CFR Part 74. This program is not subject to the intergovernmental
review requirements of Executive Order 12372 or Health Systems Agency
review.

The Public Health Service (PHS) strongly encourages all grant
recipients to provide a smoke-free workplace and promote the non-use
of all tobacco products. This is consistent with the PHS mission to
protect and advance the physical and mental health of the American
people.

Return to PA Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.